The Serum Institute of India, the world's fifth largest vaccinemaker by volume, is eyeing newer vaccines, including one for the human papillomavirus expected to be launched by late 2018 and sell at a third of the price of Merck & Co.'s blockbuster Gardasil, Bloomberg reported.
A powdered measles vaccine could mean a cheaper option for the developing world that eliminates storage, contamination and waste challenges. And researchers now have one that looks safe in Phase I.
Indian generics maker Cipla is taking its low-cost game into the vaccine field, thanks to a new deal with the Serum Institute of India.
Serum Institute of India has a history of winning shares in established vaccine markets by undercutting the competition. And now it has bought the rights to a tuberculosis vaccine it believes can beat shots by Merck and Sanofi on effectiveness, as well as cost.
Small Indian vaccine makers are starting to drum up low-cost shots for developing countries and Big Pharma wants to compete with these up-and-coming rivals. GlaxoSmithKline ($GSK) announced an agreement to team up with an Indian venture to produce a 6-in-1 vaccine to protect against polio and 5 other diseases.
India, a country forging its way into the vaccine production business, has found itself descending into the clutches of its private sector.
The Serum Institute of India will donate 20 million doses of measles-rubella vaccine to the GAVI Alliance as part of that organization's initiative to reduce the mortality rate caused by measles-rubella in the developing world.
Merck ($MRK) and the Serum Institute of India are joining forces to bring a pneumococcal conjugate vaccine to emerging and developing markets. The deal includes a product advisory committee that will
Just over a week after UNICEF began publishing vaccine prices, many vaccine producers including GlaxoSmithKline and Merck have announced they will cut their vaccine prices for developing countries.
The Bill and Melinda Gates philanthropy machine rolls on. This week the foundation is backing two firms in India researching vaccines for pneumonia and diarrhea. Both Bharat Biotech and Serum